ニューヨークにおけるクローン病の臨床試験
ニューヨーク内の拠点で、クローン病に関する36件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- New York Gastroenterology Associates ( Site 0253), New York
被験者募集中第3相
全年齢 · 全性別 · 2026/10/02更新 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Northwell Health Physician Partners Center for Advanced IBD Care ( Site 5017), Great Neck
- NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078), New York
- Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079), New York
- 他2件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Westchester Putnam Gastroenterology PC, Carmel
- Five Towns Gastroenterology, Cedarhurst
- IMIDeology, Elmhurst
- 他5件
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/25更新 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Nyu Langone Long Island Clinical Research Associates - Lake Success /ID# 265566, Lake Success
- Northwell Health-Lenox Hill Hospital /ID# 265527, New York
- Care Access - Yonkers /ID# 266781, Yonkers
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Westchester Putnam Gastroenterology, Carmel
- New York Gastroenterology Associates, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Westchester Putnam Gastroenterology, Carmel
- Inflammatory Bowel Disease Center at NYU Langone, New York
- Weill Cornell Medical College, New York
- 他2件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York
- Rochester Clinical Research, Inc, Rochester
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- New York Gastroenterology Associates, New York
- Care Access - Yonkers, Yonkers
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- MedTraits NY-Site Number: 8400045, Maspeth
- Manhattan Clinical Research, LLC-Site Number: 8400069, New York
- NYU Langone Health-Site Number: 8400091, New York
- 他4件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/23更新 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- MedTraits NY-Site Number: 8400045, Maspeth
- NYU Langone Health-Site Number: 8400091, New York
- Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040, New York
- 他1件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/23更新 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Icahn School of Medicine at Mount Sinai /ID# 254880, New York
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/23更新 · NCT05995353A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中第3相
2歳〜19歳 · 全性別 · 2026/09/22更新 · NCT04844606A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- NYU Langone Health, New York
被験者募集中第4相
18歳〜70歳 · 全性別 · 2026/09/09更新 · NCT06045754Standardized Microbiota Transplant Therapy in Crohn's Disease
- NYU Langone Health, New York
被験者募集中第2相
18歳〜89歳 · 全性別 · 2026/09/08更新 · NCT06631586A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- New York Gastroenterology Associates, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07577843A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center/New York Presbyterian, New York
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/24更新 · NCT05509777Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
- Weill Cornell Medicine, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT06274554Behavioral Therapy for Crohn's Disease
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
被験者募集中
18歳〜65歳 · 全性別 · 2026/08/12更新 · NCT06512597Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Saratoga Schenectady Gastroenterology Associates, Burnt Hills
- NYU Langone Health, New York
- Cornell University, New York
被験者募集中
18歳以上 · 全性別 · 2026/08/07更新 · NCT05230173Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- New York University, New York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/05更新 · NCT07237516Low Dose IL-2 for the Treatment of Crohn's Disease
- Mount Sinai, New York
被験者募集中第1/2相
12歳〜80歳 · 全性別 · 2026/08/03更新 · NCT04263831Autologous Stem Cell Transplant for Crohn's Disease
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/24更新 · NCT03219359Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- Icahn School of Medicine at Mount Sinai /ID# 262216, New York
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/24更新 · NCT06332534A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- New York Presbyterian Hospital, New York
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/22更新 · NCT06405087Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/06/05更新 · NCT06976853Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Cohen Children's Medical Center of NY, Lake Success
- Columbia University Medical Center, New York
被験者募集中第4相
6歳〜17歳 · 全性別 · 2026/05/27更新 · NCT05781152A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Columbia University Medical Center, New York-Presbyterian Hospital, New York
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/05/27更新 · NCT06227910Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
- Weill Cornell Medical College, New York
被験者募集中
18歳〜90歳 · 全性別 · 2026/05/14更新 · NCT03256240A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- The Steven and Alexandra Cohen Childrens Medical Center of New York - BRANY - PPDS, New Hyde Park
- Stony Brook University Medical Center, Stony Brook
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/05/05更新 · NCT04779320A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, New York
- Mirador Therapeutics Selected Site, Rochester
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/01/07更新 · NCT06001450Treatment of Moderate to Severe Refractory Crohn's Disease
- Mount Sinai Health Systems, New York
被験者募集中第1/2相
18歳〜65歳 · 全性別 · 2025/12/10更新 · NCT06721962Helmsley 3.0: Abbreviated MRE
- NYU Langone, New York
被験者募集中観察研究
10歳以上 · 全性別 · 2025/10/27更新 · NCT06533228ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。